Abstract
Transcription activator-like effectors (TALEs) are modular proteins derived from the plant Xanthomonas sp. pathogen that can be designed to target unique DNA sequences following a simple cipher. Customized TALE proteins can be used in a variety of molecular applications that include gene editing and transcriptional modulation. Presently, we provide a brief primer on the design and construction of TALEs. TALE proteins can be fused to a variety of different effector domains that alter the function of the TALE upon binding. This flexibility of TALE design and downstream effect may offer therapeutic applications that are discussed in this section. Finally, we provide a future perspective on TALE technology and what challenges remain for successful translation of gene-editing strategies to the clinic.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Boch J, Scholze H, Schornack S et al (2009) Breaking the Code of DNA Binding Specificity of TAL-Type III Effectors. Science 326(80):1509–1512. https://doi.org/10.1126/science.1178811
Mak AN-S, Bradley P, Cernadas RA et al (2012) The crystal structure of TAL effector PthXo1 bound to its DNA target. Science 335:716–719. https://doi.org/10.1126/science.1216211
Streubel J, Blücher C, Landgraf A, Boch J (2012) TAL effector RVD specificities and efficiencies. Nat Biotechnol 30:593–595. https://doi.org/10.1038/nbt.2304
Deng D, Yin P, Yan C et al (2012) Recognition of methylated DNA by TAL effectors. Cell Res 22:1502–1504. https://doi.org/10.1038/cr.2012.127
Guilinger JP, Pattanayak V, Reyon D et al (2014) Broad specificity profiling of TALENs results in engineered nucleases with improved DNA-cleavage specificity. Nat Methods 11:429–435. https://doi.org/10.1038/nmeth.2845
Römer P, Recht S, Strauß T et al (2010) Promoter elements of rice susceptibility genes are bound and activated by specific TAL effectors from the bacterial blight pathogen, Xanthomonas oryzae pv. oryzae. New Phytol 187:1048–1057. https://doi.org/10.1111/j.1469-8137.2010.03217.x
Lamb BM, Mercer AC, Barbas CF (2013) Directed evolution of the TALE N-terminal domain for recognition of all 5′ bases. Nucleic Acids Res 41:9779–9785. https://doi.org/10.1093/nar/gkt754
Meckler JF, Bhakta MS, Kim M-S et al (2013) Quantitative analysis of TALE-DNA interactions suggests polarity effects. Nucleic Acids Res 41:4118–4128. https://doi.org/10.1093/nar/gkt085
Cermak T, Doyle EL, Christian M et al (2011) Efficient design and assembly of custom TALEN and other TAL effector-based constructs for DNA targeting. Nucleic Acids Res 39:e82. https://doi.org/10.1093/nar/gkr218
Zhang F, Cong L, Lodato S et al (2011) Efficient construction of sequence-specific TAL effectors for modulating mammalian transcription. Nat Biotechnol 29:149–153. https://doi.org/10.1038/nbt.1775
Gaj T, Gersbach CA, Barbas CF III (2013) ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering. Trends Biotechnol 31:397–405. https://doi.org/10.1016/j.tibtech.2013.04.004
Joung JK, Sander JD (2013) TALENs: a widely applicable technology for targeted genome editing. Nat Rev Mol Cell Biol 14:49–55. https://doi.org/10.1038/nrm3486
Cong L, Zhou R, Kuo Y et al (2012) Comprehensive interrogation of natural TALE DNA-binding modules and transcriptional repressor domains. Nat Commun 3:968. https://doi.org/10.1038/ncomms1962
Miller JC, Tan S, Qiao G et al (2011) A TALE nuclease architecture for efficient genome editing. Nat Biotechnol 29:143–148. https://doi.org/10.1038/nbt.1755
Li T, Huang S, Jiang WZ et al (2011) TAL nucleases (TALNs): hybrid proteins composed of TAL effectors and FokI DNA-cleavage domain. Nucleic Acids Res 39:359–372. https://doi.org/10.1093/nar/gkq704
Wood AJ, Lo T-W, Zeitler B et al (2011) Targeted genome editing across species using ZFNs and TALENs. Science 333(80):307–307. https://doi.org/10.1126/science.1207773
Tesson L, Usal C, Ménoret S et al (2011) Knockout rats generated by embryo microinjection of TALENs. Nat Biotechnol 29:695–696. https://doi.org/10.1038/nbt.1940
Wefers B, Meyer M, Ortiz O et al (2013) Direct production of mouse disease models by embryo microinjection of TALENs and oligodeoxynucleotides. Proc Natl Acad Sci U S A 110:3782–3787. https://doi.org/10.1073/pnas.1218721110
Sato K, Oiwa R, Kumita W et al (2016) Generation of a nonhuman primate model of severe combined immunodeficiency using highly efficient genome editing. Cell Stem Cell 19:127–138. https://doi.org/10.1016/j.stem.2016.06.003
Carlson DF, Tan W, Lillico SG et al (2012) Efficient TALEN-mediated gene knockout in livestock. Proc Natl Acad Sci 109:17382–17387. https://doi.org/10.1073/pnas.1211446109
Kim E, Kim S, Kim DH et al (2012) Precision genome engineering with programmable DNA-nicking enzymes. Genome Res 22:1327–1333. https://doi.org/10.1101/gr.138792.112
Wu H, Wang Y, Zhang Y et al (2015) TALE nickase-mediated SP110 knockin endows cattle with increased resistance to tuberculosis. Proc Natl Acad Sci U S A 112:E1530–E1539. https://doi.org/10.1073/pnas.1421587112
Wang X, Wang Y, Wu X et al (2015) Unbiased detection of off-target cleavage by CRISPR-Cas9 and TALENs using integrase-defective lentiviral vectors. Nat Biotechnol 33:175–178. https://doi.org/10.1038/nbt.3127
Ran FA, Hsu PD, Lin C-Y et al (2013) Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity. Cell 154:1380–1389. https://doi.org/10.1016/j.cell.2013.08.021
Qasim W, Thrasher AJ (2014) Progress and prospects for engineered T cell therapies. Br J Haematol 166:818–829. https://doi.org/10.1111/bjh.12981
Maeder ML, Linder SJ, Reyon D et al (2013) Robust, synergistic regulation of human gene expression using TALE activators. Nat Methods 10:243–245. https://doi.org/10.1038/nmeth.2366
Bultmann S, Morbitzer R, Schmidt CS et al (2012) Targeted transcriptional activation of silent oct4 pluripotency gene by combining designer TALEs and inhibition of epigenetic modifiers. Nucleic Acids Res 40:5368–5377. https://doi.org/10.1093/nar/gks199
Gao X, Tsang JCH, Gaba F et al (2014) Comparison of TALE designer transcription factors and the CRISPR/dCas9 in regulation of gene expression by targeting enhancers. Nucleic Acids Res 42:e155. https://doi.org/10.1093/nar/gku836
Perez-Pinera P, Ousterout DG, Brunger JM et al (2013) Synergistic and tunable human gene activation by combinations of synthetic transcription factors. Nat Methods 10:239–242. https://doi.org/10.1038/nmeth.2361
Uhde-Stone C, Cheung E, Lu B (2014) TALE activators regulate gene expression in a position- and strand-dependent manner in mammalian cells. Biochem Biophys Res Commun 443:1189–1194. https://doi.org/10.1016/j.bbrc.2013.12.111
Zhang Z, Xiang D, Heriyanto F et al (2013) Dissecting the roles of miR-302/367 cluster in cellular reprogramming using TALE-based repressor and TALEN. Stem Cell Reports 1:218–225. https://doi.org/10.1016/j.stemcr.2013.07.002
Amabile A, Migliara A, Capasso P et al (2016) Inheritable silencing of endogenous genes by hit-and-run targeted epigenetic editing. Cell 167:219–232.e14. https://doi.org/10.1016/j.cell.2016.09.006
Fink KD, Deng P, Gutierrez J et al (2016) Allele-Specific reduction of the mutant huntingtin allele using transcription activator-like effectors in human huntington’s disease fibroblasts. Cell Transplant 25:677–686. https://doi.org/10.3727/096368916X690863
Holkers M, Maggio I, Liu J et al (2013) Differential integrity of TALE nuclease genes following adenoviral and lentiviral vector gene transfer into human cells. Nucleic Acids Res 41:e63–e63. https://doi.org/10.1093/nar/gks1446
Yang L, Guell M, Byrne S et al (2013) Optimization of scarless human stem cell genome editing. Nucleic Acids Res 41:9049–9061. https://doi.org/10.1093/nar/gkt555
Hathaway NA, Bell O, Hodges C et al (2012) Dynamics and memory of heterochromatin in living cells. Cell 149:1447–1460. https://doi.org/10.1016/j.cell.2012.03.052
Munye MM, Tagalakis AD, Barnes JL et al (2016) Minicircle DNA provides enhanced and prolonged transgene expression following airway gene transfer. Sci Rep 6:23125. https://doi.org/10.1038/srep23125
Lewis O, Woolley M, Johnson D et al (2016) Chronic, intermittent convection-enhanced delivery devices. J Neurosci Methods 259:47–56. https://doi.org/10.1016/j.jneumeth.2015.11.008
Kay MA, He C-Y, Chen Z-Y (2010) A robust system for production of minicircle DNA vectors. Nat Biotechnol 28:1287–1289. https://doi.org/10.1038/nbt.1708
Lu J, Zhang F, Kay MA (2013) A mini-intronic plasmid (MIP): a novel robust transgene expression vector in vivo and in vitro. Mol Ther 21:954–963. https://doi.org/10.1038/mt.2013.33
Lu J, Williams JA, Luke J et al (2017) A 5′ noncoding exon containing engineered intron enhances transgene expression from recombinant AAV vectors in vivo. Hum Gene Ther 28:125–134. https://doi.org/10.1089/hum.2016.140
Montague TG, Cruz JM, Gagnon JA et al (2014) CHOPCHOP: a CRISPR/Cas9 and TALEN web tool for genome editing. Nucleic Acids Res 42:W401–W407. https://doi.org/10.1093/nar/gku410
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Deng, P., Carter, S., Fink, K. (2019). Design, Construction, and Application of Transcription Activation-Like Effectors. In: Manfredsson, F., Benskey, M. (eds) Viral Vectors for Gene Therapy. Methods in Molecular Biology, vol 1937. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-9065-8_3
Download citation
DOI: https://doi.org/10.1007/978-1-4939-9065-8_3
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-9064-1
Online ISBN: 978-1-4939-9065-8
eBook Packages: Springer Protocols